PBX Share Price Performance
UK£0.068
0.02 (35.00%)
Price UK£0.068
Share PriceUK£0.068
ProBiotix Health Plc Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
PBX Community Narratives
There are no narratives available yet.
Recent PBX News & Updates
ProBiotix Health Plc Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.0047
- Gross Margin
- 53.17%
- Net Profit Margin
- -33.14%
- Debt/Equity Ratio
- 0%
ProBiotix Health Plc Competitors
Snowflake Analysis
About PBX
- Founded
- 2012
- Employees
- 8
- CEO
- WebsiteView website
ProBiotix Health Plc develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally. It offers various products, including YourBiotixMH for menopause health; YourBiotixPMH for post-menopause health; YourBiotixCH for cholesterol maintenance; YourBiotixCH InstaMelt for cholesterol health; YourBiotixBP for blood pressure reduction; and YourBiotixVH for vascular health support. The company was formerly known as ProBiotix Health Limited and changed its name to ProBiotix Health Plc in February 2022. ProBiotix Health Plc was founded in 2012 and is based in Wakefield, the United Kingdom.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
U.K. Market Performance
- 7 Days: 0.9%
- 3 Months: 6.3%
- 1 Year: 14.5%
- Year to Date: 15.0%
The market has been flat over the last week. More promisingly, the market is up 15% over the past year. Earnings are forecast to grow by 14% annually. Market details ›